林清轩更新招股书12天后通过聆讯，孙来春、高宏旗薪金大幅上调

Core Viewpoint - Lin Qingxuan Biotechnology Co., Ltd. is preparing for an IPO, having submitted an updated prospectus and is ranked first among domestic and international high-end skincare brands in China by store count [2] Financial Performance - In the first half of 2025, Lin Qingxuan's revenue increased by 93% to 1.052 billion RMB, and net profit rose by 120% to 182 million RMB, with a gross margin exceeding 82% [3] - Total revenue for the years 2022, 2023, and 2024 was 691.5 million RMB, 805 million RMB, and 1.21 billion RMB respectively, while net profit transitioned from a loss of 5.93 million RMB in 2022 to a profit of 845.18 million RMB in 2023 and 1.87 billion RMB in 2024 [5] Store Expansion and Market Position - As of June 30, 2025, Lin Qingxuan operates 554 stores nationwide, with over 95% located in shopping malls, indicating a strong retail presence [2] - The company is recognized as the leading brand in China for both domestic and international high-end skincare products based on the total number of stores [2] Product Performance - The highest revenue contribution comes from essence oils, followed by creams and masks, with product prices ranging from 200 to 800 RMB [5] - The increase in revenue is attributed to repeat purchases from existing customers and the acquisition of new customers, alongside effective promotional strategies and cost control measures [4]